M. Kaur, J. Rai, B. S. Bal, and J. Kaur, “The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus”, Int J Basic Clin Pharmacol, vol. 3, no. 5, pp. 902–907, Jan. 2017.